Brief: Anteotech Ltd Says European RAT Clinical Trial Halted
Nov 2 (Reuters) - Anteotech Ltd ADO.AX :
* EUROPEAN RAT CLINICAL TRIAL HALTED
* DECISION MADE TO HALT EUGENI SARS-COV-2 AG RDT EUROPEAN
CLINICAL
TRIAL
* TO DIVERT FUNDING FROM TRIAL TO ENABLE ACCELERATION OF
COVID- 19
FLU A / FLU B MULTIPLEX AND/OR OTHER POINT OF CARE (POC) TESTS
* FOR TIME BEING CO HAS MADE DECISION NOT TO PURSUE
ADDITIONAL
REGULATORY APPROVALS FOR SINGLE COVID-19 TEST
Source text for Eikon: ID:nASX3WnVvx
Further company coverage: ADO.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anteotech
See all newsBrief: Anteotech ADO Expands Into Japan With Life Sciences Distributor
Australia's Anteotech hits near 3-year peak on battery tech deal with South Korean firm
Brief: Anteotech Signs Strategic Collaboration And Sales Agreement Term Sheet With Xerabrid
Brief: Anteotech Appoints Interim CFO And Company Secretary
Brief: Anteotech Reports Capital Raise Of A$3.5 Million At A$0.0155 Per Share